不同肝血流阻断方式手术治疗原发性肝癌的价值分析

Analysis on the value of different hepatic blood flow occlusion methods in the treatment of primary liver cancer

目的:探讨不同肝血流阻断方式手术治疗原发性肝癌的价值。方法:将80例原发性肝癌患者进行分组,即A组(第一肝门连续阻断)、B组(中心静脉压降低的第一肝门连续阻断)、C组(中心静脉压降低的第一肝门间歇阻断)、D组(中心静脉压降低的半肝阻断),各20例。结果:A组与B组手术时间虽然无差异(P> 0. 05),但短于C组与D组(P <0. 05)。B组术中失血量均少于A组、C组、D组(P <0. 05)。术后1周C组、D组TBIL(总胆红素)、ALT(丙氨酸氨基转移酶)水平均优于A组、B组(P <0. 05)。结论:原发性肝癌行手术治疗时,中心静脉压降低的半肝阻断方式可作为首选。

Objective To explore the value of different hepatic blood flow blocking methods in the treatment of primary liver cancer. Method 80 patients with primary liver cancer were divided into groups, namely group A （ the first hepatic portal was blocked continuously） ,group B （the first hepatic portal was blocked continuously with the central venous hypotension） , group C （the first hepatic portal was blocked intermittently with the central venous hypotension）, and group D （the half- hepatic obstruction with the central venous hypotension） ,20 eases in each group. Results The operative time of group A and group B was not different （ P 〉 0. 05 ）, but shorter than that of group C and group D （ P 〈 0. 05 ）. The intraoperative blood loss of group B was lower than that of group A, group C and group D （ P 〈 0. 05 ）. The levels of TBIL （ total bilirubin） and ALT （ alanine aminotransferase） in group C and group D were better than those in group A and group B （ P 〈 0. 05 ） 1 week after surgery. Conclusion When primary hepatocellular carcinoma （HCC） choice.